I. Pedrosa-Hernández

Assessment of disease progression in dysferlinopathy A 1-year cohort study

A. Pestronk, A. Blamire, J. Mendell, 2022 .

Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale

A. Pestronk, A. Blamire, J. Mendell, 2021, Annals of neurology.

Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT.

I. Rojas-Marcos, M. Mayos, A. López de Munain, 2019, Molecular genetics and metabolism.

Assessment of disease progression in dysferlinopathy

A. Pestronk, A. Blamire, J. Mendell, 2019, Neurology.

Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach

A. Pestronk, A. Blamire, J. Mendell, 2022, Frontiers in Neurology.

Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients

M. Mayos, J. Díaz-Manera, J. Llauger, 2021, Frontiers in Neurology.

Identification of serum microRNAs as potential biomarkers in Pompe disease

I. Illa, E. Gallardo, X. Suárez-Calvet, 2019, Annals of clinical and translational neurology.